INVESTOR-FC25I20402EB78523
$495.00
Purchase for full contact information of one or more deal team members. All purchases are final and non-refundable.
Description
PE Fund
Industry Focus:
– Biopharmaceuticals
– Medical devices
– Healthcare services
– Diagnostics
Investment strategies:
1. Growth buyouts:
– Revenue: $50M-$500M
– EBITDA: $10M-$100M
2. Life sciences venture:
– Phase II clinical assets
– Specialty therapeutic focus
Key features:
– $4.8B+ capital raised
– 30+ year healthcare focus
– 15+ MD/PhDs on team
– Scientific advisory board
Growth buyouts:
– Enterprise value: $100M-$1B
– Growth rate: 15%+ CAGR
Life sciences venture:
– Funding stage: Series B-D
– Therapeutic areas: Oncology, rare disease
– Management: Proven teams
Investment size:
– Growth: $50M-$150M
– Venture: $20M-$100M
Geographic focus:
– North America
– Europe